Helsinn Demonstrates Commitment to MF CTCL with Multiple Scientific Sessions at the EORTC Cutaneous Lymphoma Meeting 2019

Lugano, Switzerland, Sept. 26 (Korea Bizwire) – Helsinn, the Swiss pharmaceutical group focused on building quality cancer care products, today announces two further abstracts have been accepted for oral presentations at the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Meeting 2019. Helsinn has also announced the acceptance of an abstract for [...]